In recent years, there has been a proliferation of research targeting various aspects of aphasia treatment. These range from studies addressing the development, theoretical underpinnings and efficacy of specific treatments to more general issues such as intensity and dose that impact learning and outcomes, regardless of the treatment being administered.
This workshop describes the procedures for administering several of the newest aphasia treatment techniques, emphasizing their theoretical background and current evidence supporting their efficacy. Treatments that target impairment and activity-participation levels will be included. Practical issues such as dosage and service delivery models that improve access to and outcomes from treatment will be discussed.
At the end of this course, participants will be able to:
This course is offered for .7 ASHA CEUs.
Intermediate, professional level.
Registration is required. Email us for more information.
This class is conducted in St. Luke's South Tower Anderson Center (5th floor) which is directly east of (and attached to) the South Tower parking garage where free parking is available.
The South Tower ground-level pedestrian entrance is just east of the cul-de-sac at the corner of W. Bannock Street and N. First Street.
Motorists should enter the South Tower parking garage at 101 W. Bannock Street and park on level 4 (top) in spaces designated for patients.
Enter the South Tower through entrance 4A, go through the double doors, and go to the 5th floor.
Dr. Cherney is the scientific chair, Think and Speak Lab, at the Shirley Ryan AbilityLab (formerly the Rehabilitation Institute of Chicago) and professor of both physical medicine and rehabilitation and communication sciences and disorders at Northwestern University. She has more than 35 years of clinical experience working with adults with neurogenic communication disorders and is the founder and director of the AbilityLab’s Center for Aphasia Research and Treatment.
Dr. Cherney is board-certified in neurologic communication disorders by the Academy of Neurologic Communication Disorders and Sciences (ANCDS) and has received the honors of ANCDS, the American Speech-Language-Hearing Association and the Illinois Speech-Language Hearing Association. She has co-authored four books and has more over 90 publications in refereed journals, textbooks and other periodicals. She regularly presents at workshops and conferences nationally and internationally.
Dr. Cherney’s research interests, which have been continuously federally funded for more than 20 years, have focused on treatment approaches for aphasia and on attention and discourse problems in adults with cognitive-communication disorders.